In vitro activity of tigecycline against resistant micro-organisms isolated from burn patients

To conclude, this study demonstrated that tigecycline exhibits in vitro activity against clinical isolates of MDR A. baumannii, MRSA, and Enterococcus spp. isolated from burn patients. Tigecycline is a promising therapeutic option for difficult to treat burn infections due to these pathogens.